66954-1-Ig

antibody from Proteintech Group

Targeting: FGFR3 ACH, CD333, CEK2, JTK4

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

66954-1-Ig

Provider

Proteintech Group

Product name

FGFR3 antibody

Antibody type

Monoclonal

Description

KD/KO validated FGFR3 antibody (Cat. #66954-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IF, WB,ELISA.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1F3G1

Vial size

20ul, 150ul

References

Submitted references

Downregulation of S100A11 promotes T cell infiltration by regulating cancer-associated fibroblasts in prostate cancer.

Han D, Guo C, Cheng H, Lu J, Hou Z, Zhang X, Luo Y, Zhang B, Zhao W, Shang P
International immunopharmacology 2024 Feb 15;128:111323

---

Tumor-Associated Fibroblast-Derived Exosomal circDennd1b Promotes Pituitary Adenoma Progression by Modulating the miR-145-5p/ONECUT2 Axis and Activating the MAPK Pathway.

Jiang Q, Lei Z, Wang Z, Wang Q, Zhang Z, Liu X, Xing B, Li S, Guo X, Liu Y, Li X, Qi Y, Shu K, Zhang H, Huang Y, Lei T
Cancers 2023 Jun 27;15(13)

---

Inhibition of FGFR3 upregulates MHC-I and PD-L1 via TLR3/NF-kB pathway in muscle-invasive bladder cancer.

Wu W, Chen L, Jia G, Tang Q, Han B, Xia S, Jiang Q, Liu H
Cancer medicine 2023 Jul;12(14):15676-15690

---

The UCMSC-bFGF/Scaffold System Accelerates the Healing of the Uterine Full-Thickness Injury.

Wang L, Yao S, Huang F, Lv H, Liu D, Gao T, Wang B, Zhou Z, Cao C, Zhu Q, Weng Q, Zhao G, Hu Y
Tissue engineering. Part A 2023 Feb;29(3-4):112-125

---

HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.

Guo K, Ma Z, Zhang Y, Han L, Shao C, Feng Y, Gao F, Di S, Zhang Z, Zhang J, Tabbò F, Ekman S, Suda K, Cappuzzo F, Han J, Li X, Yan X
Journal of experimental & clinical cancer research : CR 2022 Mar 11;41(1):91

---

Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.

Tan Z, Jiang Y, Liang L, Wu J, Cao L, Zhou X, Song Z, Ye Z, Zhao Z, Feng H, Dong Z, Lin S, Zhou Z, Wang Y, Li X, Guan F
Journal of experimental & clinical cancer research : CR 2022 Jul 21;41(1):228

---

Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer.

Kołat D, Kałuzińska Ż, Bednarek AK, Płuciennik E
Cells 2022 Apr 19;11(9)

---

The effects of Omarigliptin on promoting osteoblastic differentiation.

Liao F, Hu X, Chen R
Bioengineered 2021 Dec;12(2):11837-11846

---

FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice.

Kuang L, Wu J, Su N, Qi H, Chen H, Zhou S, Xiong Y, Du X, Tan Q, Yang J, Jin M, Luo F, Ouyang J, Zhang B, Wang Z, Jiang W, Chen L, Chen S, Wang Z, Liu P, Yin L, Guo F, Deng C, Chen D, Liu C, Xie Y, Ni Z, Chen L
Annals of the rheumatic diseases 2020 Jan;79(1):112-122